Publications - IR Sant Pau

Search

01/12/2024 Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.

Li R, Hensley PJ, Gupta S, Al-Ahmadie H, Babjuk M, Black PC, Brausi M, Bree KK, Fernández MI, Guo CC, Horowitz A, Lamm DL, Lerner SP, Lotan Y, Mariappan P, McConkey D, Mertens LS, Mir C, Ross JS, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess PE, Svatek RS, Tan WS, Taoka R, Buckley R, Kamat AM. Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.. EUROPEAN UROLOGY. 2024; 86(6)DOI:10.1016/j.eururo.2024.08.001. PMID:39183090. IF:(Q/D).

01/11/2024 p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse Prognosis.

Trias I, Algaba F, de Torres I, Saco A, Marimon L, Peñuelas N, Diez-Ahijado L, Sisuashvili L, Darecka K, Morató A, Del Pino M, Ferrándiz-Pulido C, Ribal MJ, Ajami T, Corral JM, Gaya JM, Reig O, Ordi O, Ribera-Cortada I, García-Herrera A, Rakislova N. p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse Prognosis.. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2024; 48(11)DOI:10.1097/PAS.0000000000002291. PMID:39040011. IF:(Q/D).

01/08/2025 Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases

Pérez-Montero, H, Lozano, A, de Blas, R, Hernández, J, Mera, A, Guedea, F, Navarro-Martín, A. Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases. Clinical & Translational Oncology. 2025; 27(8)DOI:10.1007/s12094-025-03878-1. PMID:40009131. IF:2.500(Q3/6D).

01/07/2025 Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel

Maldonado, X, Boladeras, A, Gaya, JM, Muñoz, J, Planas, J, Sancho, G, Suárez, JF. Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel. Clinical & Translational Oncology. 2025; 27(7)DOI:10.1007/s12094-024-03833-6. PMID:39747804. IF:2.500(Q3/6D).

01/06/2025 Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain

Najjari-Jamal, D, Rovirosa, A, Gimeno-Morales, M, Majercakova, K, Sánchez, M, Garcia, S, Guevara, D, Muñoz, T, de la Fuente, C, Micó, S, Stefanovic, M, Matute, R, Córdoba, S. Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain. Clinical & Translational Oncology. 2025; 27(6)DOI:10.1007/s12094-024-03804-x. PMID:39636497. IF:2.500(Q3/6D).

01/05/2025 Use of Postoperative Radiotherapy and Multiple Adjuvant Treatments After Surgical Removal of a Giant Retroauricular Keloid in a Pediatric Patient

Sicre, JE, Ivars, M, Heinz, OH, Ludwig, PW, Verdun, JI, Torres, EB. Use of Postoperative Radiotherapy and Multiple Adjuvant Treatments After Surgical Removal of a Giant Retroauricular Keloid in a Pediatric Patient. PEDIATRIC DERMATOLOGY. 2025; 42(3)DOI:10.1111/pde.15787. PMID:39491479. IF:1.200(Q3/7D).

01/05/2025 influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis

Crespo, SM, Montezuma, LC, Leon, X, Majercakova, K, Rojas, J, Calvet, G, Rabi, S, Piedra, MM, Juliá, JC, Sancho, G. influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2025 Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy

Monetzuma, LC, Crespo, S, Leon, X, Majercakova, K, Rojas, J, Piedra, M, Calvet, G, Rabi, S, Julia, JC, Sancho, G. Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2025 CBCT dose optimisation in prostate IGRT

Perea, AD, Sala, NJ, Martínez, AR, Pagès, MB, García, JR, Marcos, CA, Molinero, VR, Fernandez, JPA, Franco, PG, Aguilar, NT, Bargalló, HV, Rey, EMA, Martin, AR, Arnal, CF, Gomez, MVM, Parreño, IA, Moreno, SG, González, JMR, Rull, FJC, Martin, DM, Deulofeu, AM, Martínez, SB, Errasti, AM, Pardo, GS, de Fez, PC. CBCT dose optimisation in prostate IGRT. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2025 Dosimetric Impact of Different CT Image Sets on Lung SBRT Planning

Bargalló, HV, Aguilar, NT, Sala, NJ, Fernández, JPA, Marco, CA, Franco, PG, Rey, EMA, Pagès, MB, Martínez, AR, Perea, AD, Molinero, VR, García, JR, Bernardó, NF, de Fez, PC. Dosimetric Impact of Different CT Image Sets on Lung SBRT Planning. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

17/04/2025 Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?

Gomis-Sellés, E, Maldonado, A, Gaztañaga, M, Vera, V, Ajulia, O, Sancho, G, Siva, S, Lopez-Campos, F, Couñago, F. Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?. Cancers. 2025; 17(8)DOI:10.3390/cancers17081350. PMID:40282526. IF:4.400(Q2/3D).

11/03/2025 Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients

Otero-Pla, E, Raspall, MJF, Franco, PG, Martínez, JF, Saladich, IG, Sala, NJ, Gisbert, ML, Cordero, JR, Verdum, JI, Sancho-Pardo, G. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1552908. PMID:40134591. IF:3.300(Q2/4D).

01/01/2025 Economic Evaluation of Traditional Treatments for Localized Prostate Cancer: A 10-Year Cohort Study

Zamora, V, Bosch, G, Becerra, V, Garin, O, Avila, M, Gutiérrez, C, Suárez, JF, Goñi, A, Macías, V, Mariño, A, Hervás, A, Herruzo, I, Cabrera, P, de León, JP, Sancho, G, Pont, A, Rubio-Valera, M, Alonso, J, Cots, F, Guedea, F, Castells, M, Ferrer, M. Economic Evaluation of Traditional Treatments for Localized Prostate Cancer: A 10-Year Cohort Study. EUROPEAN JOURNAL OF CANCER CARE. 2025; 2025(1)DOI:10.1155/ecc/3563061. PMID:. IF:1.900(Q2/4D).

11/11/2024 MAGNETIC RESONANCE SPECTROSCOPY IN THE POST-TREATMENT METABOLIC CHARACTERIZATION OF BRAIN TUMORS OF GLIAL ORIGIN OF CENTRAL NERVOUS SYSTEM

Acosta, PM, Malaver, G, Padin, TG, Gamboa, O, Singh, C, Rodriguez, C, Balart, J, Zubieta, C, Bouleftour, W, Magné, N, Penagos, P, Fino, D. MAGNETIC RESONANCE SPECTROSCOPY IN THE POST-TREATMENT METABOLIC CHARACTERIZATION OF BRAIN TUMORS OF GLIAL ORIGIN OF CENTRAL NERVOUS SYSTEM. NEURO-ONCOLOGY. 2024; 26DOI:10.1093/neuonc/noae165.0820. PMID:. IF:13.400(Q1/1D).

01/06/2024 Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature

Mármol, MCC, Aguado, M, Cajal, TRY, Gallardo, A, Catasus, L, Gonzalez, A, Mendez, JE, Lasa, A, Arumi, M, Rubio, OG, Serra, JB, Hernandez, FM, von Deimling, A, Kommoss, FKF, Espinosa, I. Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature. Pathologica. 2024; 116(3)DOI:10.32074/1591-951X-970. PMID:38979591. IF:(Q/D).

01/06/2024 PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform

Basterretxea, L, Hernandez, A, Gurruchaga, I, Mediavilla, BG, Espinos, EL, Esteban, B, Cacho, D, Congregado, B, Belenchon, IR, Sancho, G, Lainez, N, Buchser, D, Sanguedolce, F, Lashey, M, Duran, I. PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 Evaluation of a new technique to fill the defect generated after conservative surgery for breast cancer

Garcia-Valdecasas, B, Matias, I, Capdevila, E, Isern, J, Guix, J, Llurba, E. Evaluation of a new technique to fill the defect generated after conservative surgery for breast cancer. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

01/05/2024 Outcomes of postsurgical spine SBRT. A radical therapy for spinal cord compression

P rez-Montero, H, Godino, O, L pez, L, Lin, Y, Mera, MA, Navarro-Martin, A. Outcomes of postsurgical spine SBRT. A radical therapy for spinal cord compression. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Stage III NSCLC Treatment Patterns in Spain. A Population-Based Study of the GOECP-SEOR.

Sosa-Fajardo, P, Mart n-Mart n, M, Luna-Tirado, J, Valtue a-Peydr , G, Alvarez-Gonz lez, AM, Barrientos, PM, Farr -Bernad , N, Gonz lez-del-Portillo, E, Gonz lez-Ruiz, MA, Linares, NA, Barrionuevo-Castillo, P, Blanco-Villar, M, Vera-Barrag n, V, Mateos-Dom nguez, M, Castro-G mez, JE, Pe a-Huertas, M, Zapatero-Ortu o, J, Diezhandino, P, Eito-Valdovinos, C, Guerrero-G mez, L, Bobo-Jaureguizar, A, V zquez-Barreiro, B, Rico-Oses, M, Cou ago, F. Stage III NSCLC Treatment Patterns in Spain. A Population-Based Study of the GOECP-SEOR.. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Validation of the dosimetric accuracy of MR-only treatment planning solution for prostate cancer

Tejedor, N, Jornet, N, Gallego, P, Sancho, G, Soto-Cambres, AM, Mera, A, P rez-Alija, J, Ans n, C, Vivancos, H, Ruiz, A, Barcel , M, Leo, F, Dom nguez, A, Riu, V, Carrasco, P. Validation of the dosimetric accuracy of MR-only treatment planning solution for prostate cancer. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Could radiotherapy be avoided in poor prognosis spinal cord compression?

P rez-Montero, HM, Lin, Y, Mera, MA, Guedea, F, Navarro, A. Could radiotherapy be avoided in poor prognosis spinal cord compression?. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Dosimetric impact of individual fraction vs first fraction optimization in vaginal HDR brachytherapy

Tejedor, N, Montezuma, L, Vivancos, H, Jornet, N, P rez-Alija, J, Gallego, P, Ans n, C, Ruiz, A, Barcel , M, Fuentes, MJ, Leo, F, Dom nguez, A, Riu, V, Carrasco, P, Sancho, G, Majercakova, K. Dosimetric impact of individual fraction vs first fraction optimization in vaginal HDR brachytherapy. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Use of Social Media in Radiation Oncology: Multicenter Data from the GOCO Group

Bonet, M, Recalde, E, Soto-Cambres, AM, Martinez, A, Murcia, M, Nu ez, M, Mases, J, Yufera, JC, Alvarez, A, Feltes, N, Hernandez, L, Ramos, L, Garcia, V. Use of Social Media in Radiation Oncology: Multicenter Data from the GOCO Group. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Phase II trial of hypofractionated postoperative radiotherapy in prostate cancer: NCT04484038

Herv s, A, Zapatero, A, Carballo, AM, Rodr guez, A, Barrado, M, Salinas, A, Eito, C, Pe as, M, L pez-Campos, F, Cou ago, F, de Vidales, CM, Otero, A, Samper, P, Peleteiro, P, Depiaggio, MS, Guerrero, L, Porras, M, Lozano, AJ, P rez, R, Rodr guez-Melc n, I, Caballero, B, Vasquez, WA, Alv rez, A, Sancho, G, L zaro, J. Phase II trial of hypofractionated postoperative radiotherapy in prostate cancer: NCT04484038. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Impact of dose escalation on positive nodes in prostate cancer patients with pelvic nodal disease

Errasti, AM, Soto-Cambres, AM, Mitre, SJR, Ni o, LM, Calvet, G, Perez-Montero, H, Pardo, GS. Impact of dose escalation on positive nodes in prostate cancer patients with pelvic nodal disease. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 IS REIRRADIATION IN GYNAECOLOGICAL CANCER A REALITY? : A NATIONAL (SPANISH) SURVEY

Najjari-Jamal, D, Cordoba-Largo, S, Rovirosa, A, Sanchez-Belda, M, Majercakova, K, Garcia-Cabezas, S, Gimeno-Morales, M, Guevara-Barrera, D, Mu oz, T, De La Fuente, C, Mico, S, Matute, R. IS REIRRADIATION IN GYNAECOLOGICAL CANCER A REALITY? : A NATIONAL (SPANISH) SURVEY. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 EBH abdominal SBRT: inter- and intrafraction motion using two commercial monitoring systems

Ans n, C, Carrasco, P, Bermejo, S, Jimenez, J, Ventosa, N, Balart, J, Jornet, N, Gallego, P, P rez-Alija, J, Tejedor, N, Vivancos, H, Ruiz, A, Barcel , M, Leo, F, Dom nguez, A, Riu, V, Sancho, G. EBH abdominal SBRT: inter- and intrafraction motion using two commercial monitoring systems. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Impact of coaching reinforcement on SGRT-guided abdominal SBRT with expiration breath-hold (EBH)

Bermejo, S, Ans n, C, Carrasco, P, Jim nez, J, Ventosa, N, de Segura, GG, Balart, J, Otero, E, Vizuete, A, Domenech, J, Suri ach, F, Soto, A, Farr , N, Jornet, N, Sancho, G. Impact of coaching reinforcement on SGRT-guided abdominal SBRT with expiration breath-hold (EBH). RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Prognostic ability of TGF-ß and IL-6 in patients with HNSCC treated with RT

Montezuma, L, Leon-Vintr , X, Majerc kov , K, Juli , J, Farr , N, Rojas, J, Rabi, S, Crespo, S, Calvet, G, Camacho, M, Sancho, G. Prognostic ability of TGF-ß and IL-6 in patients with HNSCC treated with RT. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Clinical and dosimetric predictors of cardiotoxicity for locally advanced lung cancer

Pla, EO, Cambres, AMS, Franco, PG, Sala, NJ, Rabi, S, P rez, SMC, Molinas, GC, Beltr n, JS, Recio, SM, Mart nez, SB, Pardo, GS, Bernad , NF. Clinical and dosimetric predictors of cardiotoxicity for locally advanced lung cancer. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

01/05/2024 Treatment of rectal cancer in elderly patients >80 years might not be limited by their age

Pla, EO, Garc a, AJ, L pez, LR, Sanahuja, JCJ, Rabi, S, Molinas, GC, P rez, SMC, L pez-Bravo, DP, Manrique, ACV, Cullell, BM, Rodr guez, JB, S nchez, MCM, Pardo, GS, Serra, JB. Treatment of rectal cancer in elderly patients >80 years might not be limited by their age. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

11/02/2024 Criteria and indicators to evaluate quality of care in genitourinary tumour boards

Puente, J, Arrea, FA, Rueda, OB, Gauna, DC, Durán, I, Avila, JJF, Gómez-Iturriaga, A, Blázquez, MJP, Fentes, DP, Pardo, GS, Casas, JAV, Gratal, P, Pardo, MT, Porta, VG. Criteria and indicators to evaluate quality of care in genitourinary tumour boards. Clinical & Translational Oncology. 2024; 26(7)DOI:10.1007/s12094-024-03381-z. PMID:38341809. IF:2.500(Q3/6D).

01/02/2024 PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.

Cacho, D, Congregado, B, Belenchon, IR, Espinos, EL, Basterretxea, L, Sancho, G, Lainez, N, Buchser, D, Sanguedolce, F, Gurruchaga, I, Mediavilla, BG, Esteban, B, Hernandez, A, Lashey, M, Duran, I. PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(4_SUPPL)DOI:10.1200/JCO.2024.42.4_suppl.114. PMID:. IF:41.900(Q1/1D).

01/02/2024 Criteria and indicators to evaluate quality of care in genitourinary tumor boards.

Puente, J, Arrea, FA, Buisán, O, Castellano, D, Duran, I, Avila, JJF, Gómez-Iturriaga, A, Blázquez, MJP, Fentes, DP, Sancho, G, Casas, JAV, Gratal, P, Pardo, MT, Guillem, V. Criteria and indicators to evaluate quality of care in genitourinary tumor boards.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(4_SUPPL)DOI:10.1200/JCO.2024.42.4_suppl.388. PMID:. IF:41.900(Q1/1D).

03/01/2024 Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach

Martinez-Recio, S, Barba, A, Farré, N, Majem, M. Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach. Chinese Clinical Oncology. 2024; 13(2)DOI:10.21037/cco-23-118. PMID:38199796. IF:(Q/D).

01/01/2024 Use of social media in radiation oncology: multicenter data from the GOCO Group

Bonet, M, Recalde, E, Soto, A, Martinez, A, Murcia, M, Mases, J, Fernandez, MN, Yufera, JC, Alvarez, A, Eraso, MA, Feltes, N, Hernandez, L, Bernard, P, Ramos, L, Garcia, V. Use of social media in radiation oncology: multicenter data from the GOCO Group. Reports Of Practical Oncology And Radiotherapy. 2024; 29(2)DOI:10.5603/rpor.100386. PMID:39143971. IF:(Q/D).

01/09/2023 Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic

Oladeru, OT, Dunn, SA, Li, J, Coles, CE, Yamauchi, C, Chang, JS, Cheng, SHC, Kaidar-Person, O, Meattini, I, Ramiah, D, Kirby, A, Hijal, T, Marta, GN, Poortmans, P, Isern-Verdum, J, Zissiadis, Y, Offersen, BV, Refaat, T, Elsayad, K, Hijazi, H, Dengina, N, Belkacemi, Y, Luo, FD, Lu, S, Griffin, C, Collins, M, Ryan, P, Larios, D, Warren, LE, Punglia, RS, Wong, JS, Spiegel, DY, Jagsi, R, Taghian, A, Bellon, JR, Ho, AY. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. Jco Global Oncology. 2023; 9DOI:10.1200/GO.23.00010. PMID:37471670. IF:(Q/D).

13/06/2023 Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

Lococo F., Boldrini L., Diepriye, CD, Evangelista J., Nero C., Flamini S., Minucci A., De Paolis E., Vita E., Cesario A., Annunziata S., Calcagni M.L., Chiappetta M., Cancellieri A., Larici A.R., Cicchetti G., Troost, EGC, Róza Á., Farré N., Ozturk, E, Van Doorne D., Leoncini F., Urbani A., Trisolini R., Bria E., Giordano A., Rindi G., Sala E., Tortora G., Valentini V., Boccia S., Margaritora S., Scambia G.. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study. BMC CANCER. 2023; 23(1)DOI:10.1186/s12885-023-10997-x. PMID:37312079. IF:3.400(Q2/4D).

01/05/2023 Results of radiotherapy in oropharyngeal carcinomas

León X., Farré N., Montezuma L., Holgado A., Vásquez R., Neumann E., Quer M.. Results of radiotherapy in oropharyngeal carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(3)DOI:10.1016/j.otorri.2022.04.002. PMID:37149134. IF:(Q/D).

01/05/2023 hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer

Moreno-Acosta, P, Gamboa, O, Gonzalez-Prieto, C, Romero-Rojas, A, Serra, JB, Diaz, GD, Malaver, G, Bouleftour, W, Magne, N. hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer. RADIATION RESEARCH. 2023; 199(5)DOI:10.1667/RADE-22-00121.1. PMID:36888727. IF:2.500(Q2/4D).